Gujarat Kidney & Super Speciality IPO GMP: Day 2 IPO Live Updates

The Gujarat Kidney and Super Speciality IPO GMP is ₹3.5 as of 22nd December 2025. It is a book-building issue IPO of ₹250.80 crores. This is an entirely fresh issue of 2.20 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 30th December 2025. The face value of  Gujarat Kidney and Super Speciality IPO shares is ₹2 per share, and the IPO price band is ₹108 to ₹114 per share. Retail investors can bid for a minimum of 1 lots of 128 shares worth ₹14,592

Gujarat Kidney and Super Speciality IPO GMP Grey Market Premium

As mentioned earlier, the Gujarat Kidney and Super Speciality IPO GMP currently stands at ₹3.5 per share. Thus, the estimated listing price would be flat at ₹117.5. This indicates that the estimated listing gain in this IPO could be 3.07%. Explore the table for Riddhi Display Equipment IPO GMP updates.

Note: GMP details are subject to change based on market conditions and fluctuations. Check live Gujarat Kidney and Super Speciality IPO GMP status at Univest.

Gujarat Kidney and Super Speciality IPO Details

Also Read: Gujarat Kidney and Super Speciality IPO GMP & Review: Apply or Avoid?

Explanation

Gujarat Kidney and Super Speciality IPO: Gujarat Kidney and Super Speciality IPO Limited has declared an issue price band of ₹108 to ₹114 per share. With this IPO, the company allows retail investors to bid for at least 1 lots of 128 shares, each worth ₹14,592. The face value of Gujarat Kidney and Super Speciality IPO Limited shares is ₹2 per share. The shares of Gujarat Kidney and Super Speciality IPO Limited will be listed on BSE and NSE on its tentative listing day, 30th December 2025. Scroll down to check GMP updates and Gujarat Kidney and Super Speciality IPO reviews. 

Gujarat Kidney and Super Speciality IPO Objectives

The primary aim of the Gujarat Kidney and Super Speciality IPO is to raise ₹250.80 crores. On the other hand, Gujarat Kidney and Super Speciality has decided to utilise these funds in different ways.

• The proposed acquisition of Parekhs Hospital at Ahmedabad.
• To Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”.
• To fund the capital expenditure requirements of the Company towards setting up a new hospital in Vadodara.
• To buy robotics equipment for our hospital, Gujarat Kidney and Super Speciality Hospital in Vadodara.
• To Full or partial repayment and/or prepayment of certain outstanding secured borrowings availed by the Company
• To fund inorganic growth through unidentified acquisitions and General Corporate Purposes.
• To acquire additional shareholding in the subsidiary, namely “Harmony Medicare Private Limited” at Bharuch

Gujarat Kidney and Super Speciality IPO Registrar

MUFG Intime India Private Limited is the registrar for the Gujarat Kidney and Super Speciality IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Gujarat Kidney and Super Speciality allotment and refund, you can contact MUFG Intime India Private Limited at gujaratkidney.ipo@in.mpms.mufg.com or at  +91-22-4918 6270.

Gujarat Kidney and Super Speciality IPO Review

The Gujarat Kidney and Super Speciality IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Gujarat Kidney and Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024  to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Gujarat Kidney and Super Speciality IPO or not.

The PE ratio of Gujarat Kidney and Super Speciality Limited shares is 61.62, and its Earnings Per Share (EPS) stands at 1.85. Thus, the Gujarat Kidney and Super Speciality IPO can deliver gains on its tentative listing date, 30th December 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Gujarat Kidney and Super Speciality Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

FAQs on Gujarat Kidney and Super Speciality IPO

What is the Gujarat Kidney and Super Speciality IPO GMP?

Currently, on 23rd December 2025, the Gujarat Kidney and Super Speciality IPO GMP (Grey Market Premium) stands at ₹3.5. This indicates that the estimated listing price could be ₹117.50 per share.

What is the issue price of Gujarat Kidney and Super Speciality IPO?

The Gujarat Kidney and Super Speciality IPO issue price band is set at ₹108.00 to ₹114.00 per share. Retail investors can apply for a minimum of 1 lots, each consisting of 128 shares, worth ₹14,592. Moreover, HNIs are required to bid for a minimum of 14 lots (1,792 shares) worth ₹2,04,256.

Who is the registrar of the Gujarat Kidney and Super Speciality IPO?

 MUFG Intime India Private Limited is the registrar for the Gujarat Kidney and Super Speciality IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Gujarat Kidney and Super Speciality allotment and refund, you can contact MUFG Intime India Private Limited at gujaratkidney.ipo@in.mpms.mufg.com or at  +91-22-4918 6270.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Gujarat Kidney and Super Speciality IPO, download the Gujarat Kidney and Super Speciality IPO RHP and Gujarat Kidney and Super Speciality IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Ravelcare IPO GMP: Day 3 IPO Live Updates

Astron Multigrain IPO Subscription Day 2

Astron Multigrain IPO GMP: Day 2 IPO Live Updates

Invicta Diagnostic IPO Subscription Day 2

Invicta Diagnostic IPO GMP: Day 2 IPO Live Updates

Gujarat Kidney and Super Speciality  IPO GMP & Review: Apply or Avoid?